CG Oncology (CGON) Return on Capital Employed (2024 - 2026)
CG Oncology posted quarterly Return on Capital Employed of 23.16% for Q1 2026, down 446.0% year-on-year from 6.69% in Q1 2025, and up 11.39% on a QoQ basis from 26.14% in Q4 2025.
CG Oncology (CGON) has 3 years of Return on Capital Employed data on file, last reported at 23.16% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 446.0% year-over-year to 23.16%; the trailing twelve-month figure through Mar 2026 stood at 23.16% (down 446.0% YoY), and the FY2025 full-year result was 25.7%, down 53.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 23.16%, up from 26.14% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 14.6% in Q2 2024 and bottomed at 26.29% in Q3 2025.
- The 3-year median for Return on Capital Employed is 18.7% (2025), against an average of 20.63%.
- Peak annual rise in Return on Capital Employed reached 71 bps in 2025, while the deepest fall reached 861 bps in 2025.
- A 3-year view of Return on Capital Employed shows it stood at 18.14% in 2024, then plunged by 44 bps to 26.14% in 2025, then climbed by 11 bps to 23.16% in 2026.
- The last three Return on Capital Employed figures came in at 23.16% (Q1 2026), 26.14% (Q4 2025), and 26.29% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | -23.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.16% |
| Dec 31, 2025 | -26.14% |
| Sep 30, 2025 | -26.29% |
| Jun 30, 2025 | -22.98% |
| Mar 31, 2025 | -18.70% |
| Dec 31, 2024 | -18.14% |
| Sep 30, 2024 | -17.68% |
| Jun 30, 2024 | -14.60% |
| Mar 31, 2024 | -17.98% |